RetractedArticleOncogene2024

Retraction Note: Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin.

L Damiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.